The Federal Executive Council (FEC) on Wednesday approved the revised National Biotechnology Policy 2026, as part of efforts to position Nigeria to take advantage of emerging opportunities in the global bio-economy and strengthen the country’s capacity to develop and commercialise biotechnology solutions.
The Minister of Innovation, Science and Technology, Kingsley Udeh, disclosed the council’s decision while briefing State House correspondents at the end of the meeting in Abuja, describing the approval as an important step towards strengthening Nigeria’s science, technology, and innovation ecosystem.
The revised policy is expected to provide a broader framework for the development and application of biotechnology across sectors, while encouraging innovation, research, investment, skills development, and the responsible commercialisation of biotechnology-based solutions.
FEC Backs Biotechnology Development
The approval reflects the Federal Government’s growing focus on science and technology as instruments for economic diversification and national development.
Furthermore, biotechnology has applications across several areas of the economy, including agriculture, healthcare, pharmaceuticals, food production, environmental management, industrial manufacturing, and other emerging sectors.
A coordinated national policy can help provide direction for researchers, institutions, businesses, investors, and government agencies operating within the biotechnology ecosystem.
It can also help create a more predictable environment for developing technologies from research laboratories into practical products and services.
Nigeria Seeks Role in Global Bio-Economy
The global bio-economy is creating new opportunities through the use of biological resources, biotechnology, advanced research, and innovative production methods.
Furthermore, countries are increasingly investing in biotechnology because of its potential to improve productivity, develop new products, strengthen healthcare systems, increase agricultural yields, and create new industries.
Nigeria’s large population, agricultural resources, research institutions, and growing technology ecosystem provide opportunities for greater participation in this emerging economy.
The revised policy could therefore provide a strategic framework for Nigeria to build domestic capacity while identifying areas where local research and innovation can compete internationally.
Agriculture Could Benefit
Agriculture remains one of the sectors where biotechnology could have significant implications for Nigeria.
Furthermore, biotechnology can support the development of improved crop varieties, disease-resistant plants, better soil management techniques, and other technologies aimed at increasing agricultural productivity.
Greater adoption of biotechnology could help farmers respond to climate-related challenges and improve food production.
It could also support the development of more efficient agricultural value chains while reducing some of the constraints affecting productivity.
Healthcare and Pharmaceuticals
The healthcare sector could also benefit from stronger biotechnology development.
Furthermore, biotechnology can support research into medicines, vaccines, diagnostics, therapeutic products, and other healthcare technologies.
Building stronger domestic capacity could reduce dependence on imported technologies in some areas while creating opportunities for Nigerian researchers and companies to participate in pharmaceutical and biotechnology value chains.
The policy could also encourage collaboration between research institutions, universities, healthcare organisations, and private companies.
Research and Innovation Capacity
The successful implementation of the revised policy will depend heavily on Nigeria’s ability to strengthen its research and development capacity.
Furthermore, universities, research institutions, laboratories, technology companies, and government agencies will need appropriate funding, infrastructure, equipment, and skilled professionals to translate scientific discoveries into practical applications.
Investment in research can create new technologies.
Training can develop specialised professionals.
Industry partnerships can accelerate commercialisation.
These elements will be important for ensuring that biotechnology research produces measurable economic and social benefits.
Opportunities for Young Scientists
The policy could also create opportunities for Nigerian scientists, engineers, researchers, entrepreneurs, and technology professionals to participate in emerging biotechnology industries.
Furthermore, developing specialised skills will be important as biotechnology becomes increasingly connected with areas such as artificial intelligence, advanced manufacturing, data science, pharmaceuticals, agriculture, and environmental technologies.
Supporting young researchers could help build a new generation of biotechnology professionals capable of developing locally relevant solutions.
Attracting Private Investment
Private-sector investment will also be important to the success of Nigeria’s biotechnology ambitions.
Furthermore, government funding alone may not be sufficient to develop laboratories, commercial-scale production facilities, research platforms, and biotechnology companies capable of competing in international markets.
A clear policy framework can improve investor confidence.
Partnerships can provide additional capital.
Commercialisation can create new businesses.
Stronger intellectual property protection can also encourage researchers and companies to invest in innovative technologies.
Responsible Biotechnology Development
As biotechnology advances, effective regulation will remain important to ensure that new technologies are developed and deployed responsibly.
Furthermore, appropriate standards can help address concerns involving biosafety, biosecurity, environmental protection, ethical research, data management, and public confidence.
A balanced approach can encourage innovation while protecting public health and the environment.
Strong institutions will therefore be required to support effective implementation and monitoring of the policy.
Strengthening Nigeria’s Economic Diversification
The revised biotechnology policy could contribute to the Federal Government’s broader efforts to diversify the economy beyond traditional sources of revenue.
Furthermore, biotechnology-based industries can create opportunities for manufacturing, exports, employment, research, and technology development.
Developing local biotechnology value chains could enable Nigeria to move beyond consuming imported technologies and become a producer of innovative biological products and services.
Looking Ahead
The Federal Executive Council’s approval of the revised National Biotechnology Policy 2026 provides a new policy framework for strengthening Nigeria’s biotechnology ecosystem and positioning the country to participate more actively in the expanding global bio-economy.
The effectiveness of the policy, however, will depend on implementation, funding, research infrastructure, skilled manpower, regulatory coordination, private-sector participation, and the ability to translate scientific discoveries into commercially viable solutions.
Ultimately, the revised policy could help Nigeria unlock the economic and social potential of biotechnology by connecting research, innovation, investment, agriculture, healthcare, manufacturing, and entrepreneurship within a coordinated national framework designed to strengthen the country’s position in the global bio-economy.
